Showing results (211-220 of 250) with videos related to
Sort By:
Pageof 25
Lancet (London, England)|October 29, 1983
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levelsF H Messerli, K Sundgaard-Riise, H O Ventura, et al.Angiology|September 1, 1975
Labile (borderline) hypertension--new aspects of a common disorderO Kuchel, J L Cuche, P Hamet, et al.Archives of Internal Medicine|June 1, 1989
Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmiasF H Messerli, B D Nunez, M M Nunez, et al.Hypertension (Dallas, Tex. : 1979)|November 1, 1981
Antiadrenergic therapy: special aspects in hypertension in the elderlyF H Messerli, G R Dreslinski, F E Husserl, et al.Circulation Research|June 1, 1976
Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertensionF H Messerli, O Kuchel, P Hamet, et al.Journal of the American College of Cardiology|May 1, 1983
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexesF G Dunn, W Oigman, K Sungaard-Riise, et al.Canadian Medical Association Journal|May 7, 1977
Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertensionO Kuchel, F H Messerli, G Tolis, et al.Circulation|March 1, 1976
Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activityF H Messerli, O Kuchel, W Nowaczynski, et al.Circulation|June 1, 1984
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertensionH O Ventura, F H Messerli, E D Frohlich, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1982
Genetic control of C6 polymorphism and C6 deficiency in rabbitsM B Goldman, C Cohen, K Stronski, et al.Pageof 25